Manhattan Research (New York), which has carved out a proprietary space in use of digital media by healthcare providers, released its 2012 Taking the Pulse survey in May; for the first time, the surveying company did all its work online, with no telephone queries, “due to the near ubiquitous online access among US physicians.”
Highlights of the survey are: the meteoric rise of the interactive tablet (primarily, the Apple iPad), now owned or used for professional purposes by 62% of physicians; and a surprising flattening of interest in social media sites for clinical consulting (common among only 7% of physicians), while traditional telephone interactions or face-to-face meetings are the medium of engagement for 81% and 64% of physicians, respectively. Manhattan Research concludes that for social media channels, there is a “low value proposition” and “privacy concerns [are] still a barrier,” according to Monique Levy, VP of research for the company.
Along with the growth of tablet usage, the “three screen” physician is now common: making use of a desktop/laptop; a smartphone; or a tablet. Somewhat surprisingly, one device does not cannibalize another; the more screens physicians use, the more time they spend online.
JOURNALS, COLLEAGUES ARE THE LEADING INFLUENCES ON CLINICAL DECISIONS. credit: Manhattan Research
Information influence
Manhattan Research also polled respondents broadly about their informational influences on clinical decisions (see Figure). As can be expected, peer interactions with colleagues (mostly offline) is the dominant source, both in frequency and in influence. But professional journals (online or offline) are quite high. Pharma reps are strong in reach, but less so in influence. Continuing medical education (CME) and conferences (online and offline) are average influencers, with CME providing more reach.
Within the subset of online learning, Manhattan Research finds that physicians are avid users of online video, especially for CME, online lectures, and disease or condition information. The top destinations for accessing professional videos are WebMD Professional Network, YouTube, QuantiaMD, pharma industry sites, and professional associations.
Taking the Pulse is one part of a comprehensive polling and analytical service from the company; the data are subdivided by physician specialties, and by hardware platforms. Other surveys look at therapeutic segmentations, consumer activities and geographic variations.
Social media sites are stuck on a plateau among physicians
Latest Manhattan Research market study finds little growth in social media usage; also, the rise of the 'three screen' physician
Manhattan Research (New York), which has carved out a proprietary space in use of digital media by healthcare providers, released its 2012 Taking the Pulse survey in May; for the first time, the surveying company did all its work online, with no telephone queries, “due to the near ubiquitous online access among US physicians.”
Highlights of the survey are: the meteoric rise of the interactive tablet (primarily, the Apple iPad), now owned or used for professional purposes by 62% of physicians; and a surprising flattening of interest in social media sites for clinical consulting (common among only 7% of physicians), while traditional telephone interactions or face-to-face meetings are the medium of engagement for 81% and 64% of physicians, respectively. Manhattan Research concludes that for social media channels, there is a “low value proposition” and “privacy concerns [are] still a barrier,” according to Monique Levy, VP of research for the company.
Along with the growth of tablet usage, the “three screen” physician is now common: making use of a desktop/laptop; a smartphone; or a tablet. Somewhat surprisingly, one device does not cannibalize another; the more screens physicians use, the more time they spend online.
JOURNALS, COLLEAGUES ARE THE LEADING INFLUENCES ON CLINICAL DECISIONS. credit: Manhattan Research
Information influence
Manhattan Research also polled respondents broadly about their informational influences on clinical decisions (see Figure). As can be expected, peer interactions with colleagues (mostly offline) is the dominant source, both in frequency and in influence. But professional journals (online or offline) are quite high. Pharma reps are strong in reach, but less so in influence. Continuing medical education (CME) and conferences (online and offline) are average influencers, with CME providing more reach.
Within the subset of online learning, Manhattan Research finds that physicians are avid users of online video, especially for CME, online lectures, and disease or condition information. The top destinations for accessing professional videos are WebMD Professional Network, YouTube, QuantiaMD, pharma industry sites, and professional associations.
Taking the Pulse is one part of a comprehensive polling and analytical service from the company; the data are subdivided by physician specialties, and by hardware platforms. Other surveys look at therapeutic segmentations, consumer activities and geographic variations.
Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy Launches
How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
Incorporating AI into Commercialization Plans
Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.
Access Insights 2024: Analyzing Drug Pricing and Reimbursement Data Amid a New Wave of CMS Price Requirements
The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena.
Access Insights 2024: Commercialization’s Financial Headwinds and Tailwinds
The conference’s opening keynote sets the scene for 2025 and the years to come.
Who Moved My Prescription? Part VI: Abandonment of Branded Prescriptions
Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.
Xofluza Significantly Reduces Household Influenza Transmission
Results of the Phase III CENTERSTONE study demonstrated that when Xofluza is taken by an individual with influenza, it lowers the risk of others in the household contracting it.
Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy Launches
How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
Incorporating AI into Commercialization Plans
Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.
Access Insights 2024: Analyzing Drug Pricing and Reimbursement Data Amid a New Wave of CMS Price Requirements
The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena.
Access Insights 2024: Commercialization’s Financial Headwinds and Tailwinds
The conference’s opening keynote sets the scene for 2025 and the years to come.
Who Moved My Prescription? Part VI: Abandonment of Branded Prescriptions
Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.
Xofluza Significantly Reduces Household Influenza Transmission
Results of the Phase III CENTERSTONE study demonstrated that when Xofluza is taken by an individual with influenza, it lowers the risk of others in the household contracting it.